Latest news with #RM15.5
New Straits Times
06-05-2025
- Business
- New Straits Times
Malaysia's financial markets remain resilient amid global volatility: FMC
KUALA LUMPUR: Malaysia's financial markets have remained stable and orderly despite persistent global volatility, the Financial Markets Committee (FMC) said in its latest assessment. This assurance comes as global investors react to the United States' sweeping tariff announcement on April 2, 2025, which has shaken market sentiment and renewed fears over the direction of global trade policy. FMC chairman and Bank Negara Malaysia deputy governor Adnan Zaylani said the strength of Malaysia's markets has allowed regulators to maintain their focus on long-term development. "The Malaysian financial markets have remained orderly despite the volatile external environment. This allows us to focus our efforts on market development initiatives that will further enhance investors' experience in our markets. "Nonetheless, we remain vigilant amid the rapidly evolving global situation," said FMC chairman and Bank Negara Malaysia deputy governor Adnan Zaylani. The US tariff move has triggered jitters among global investors, leading to cautious investment sentiments and renewed concerns over global trade policy directions. Despite initial shocks, Malaysia's financial indicators have shown encouraging signs. "The ringgit has appreciated by 2.3 per cent year-to-date against the US dollar, largely driven by broad-based dollar weakness across global markets," FMC said in a statement. Meanwhile, the domestic equity market, represented by the FBM KLCI, initially saw a sharp 8.2 per cent drop in reaction to the tariff news but recovered significantly following a temporary pause in its implementation. As of April 25, the index stood just 1.1 per cent below its level at the start of April. The foreign exchange market remains robust, with average daily turnover at US$18.8 billion so far this year—marking a 6.8 per cent year-on-year increase, according to the committee. This sustained activity continues to support corporate forex needs. In terms of fixed-income performance, the domestic bond market has shown strong investor demand. The average bid-to-cover ratio for government bond auctions has improved to 3.01 in 2025, up from 2.56 in 2024. Secondary market liquidity has also surged, with average daily trading volume rising to RM7.3 billion this year compared to RM4.6 billion in 2024, reaching a peak of RM15.5 billion. The FMC also noted increasing interest in the use of local currencies for cross-border trade and investment settlements, reflecting growing regionalisation of financial activities. Looking ahead, the FMC expressed support for Bank Negara's ongoing efforts to strengthen the Malaysian Government Investment Issue (MGII) market. It said these will include a review of the dynamic hedging framework to facilitate hedging by index trackers as well as supporting market-making by domestic financial institutions through improved repo availability.
Korea Herald
03-05-2025
- Business
- Korea Herald
CPHI South East Asia 2025: Your gateway to ASEAN's expanding pharmaceutical landscape
KUALA LUMPUR, Malaysia, May 2, 2025 /PRNewswire/ -- As Southeast Asia's pharmaceutical industry rapidly evolves—driven by regulatory harmonization, innovation, and growing healthcare demand—CPHI South East Asia 2025 provides a vital platform to connect with regional stakeholders, showcase breakthroughs, and unlock business opportunities across the ASEAN region. Taking place for the first time in Kuala Lumpur, Malaysia, from 16–18 July 2025, the event will bring together 8,000+ professionals, 400+ global exhibitors, and curated buyers from across Asia and beyond—positioning it as the region's most impactful pharma event. Unlock Growth Across ASEAN's Pharma Markets From Indonesia, Thailand, Vietnam, the Philippines to Malaysia, Southeast Asia is one of the world's most dynamic pharmaceutical regions. Governments are investing in local manufacturing, reforming regulatory systems, and opening doors to international partnerships. Malaysia, as this year's host, plays a central role in this growth. [1] The country's pharmaceutical market is expected to rise from RM11.2 billion in 2022 to RM15.5 billion by 2027, supported by the New Industrial Master Plan (NIMP) 2030, which incentivizes the production of APIs, biologics, and vaccines. [2] Strategically located between Singapore and Indonesia, Malaysia offers streamlined access to regional distributors, CDMOs, and packaging partners—making Kuala Lumpur a strategic gateway to ASEAN-wide expansion.
